scholarly journals Long-term outcome in a case of translocated mitral valve replacement for massive mitral annular calcification

2017 ◽  
Vol 5 (4) ◽  
pp. 454-457
Author(s):  
Go Kataoka ◽  
Kiyoharu Nakano ◽  
Ryota Asano ◽  
Atsuhiko Sato ◽  
Wataru Tatsuishi
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Annular Calcification ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Annular Calcification

Mitral valve replacement in children: predictors of long-term outcome

2003 ◽  
Vol 76 (3) ◽  
pp. 853-859 ◽  
Author(s):  
Brian K Eble ◽  
William P Fiser ◽  
Pippa Simpson ◽  
Judith Dugan ◽  
Jonathan J Drummond-Webb ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Long-term outcome after mitral valve replacement using biological versus mechanical valves

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Ayse Cetinkaya ◽  
Julia Poggenpohl ◽  
Karin Bramlage ◽  
Stefan Hein ◽  
Mirko Doss ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Mechanical Valves

Long-Term Outcome After Annular Mechanical Mitral Valve Replacement in Children Aged Less Than Five Years

2010 ◽  
Vol 90 (5) ◽  
pp. 1570-1576 ◽  
Author(s):  
Roland Henaine ◽  
Joseph Nloga ◽  
Fabrice Wautot ◽  
Naoki Yoshimura ◽  
Muriel Rabilloud ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome

Effects of Pregnancy on Long-Term Follow-Up of Mitral Valve Bioprostheses

1998 ◽  
Vol 6 (3) ◽  
pp. 174-178
Author(s):  
Mustafa Emir ◽  
Gürkan Uzunonat ◽  
Birol Yamak ◽  
A Tulga Ulus ◽  
M Kamil Göl ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Structural Valve Deterioration ◽  
Group 2 ◽  
Group 1

Between 1986 and 1990, 304 females between 11 and 45 (mean, 33.9 ± 6.9) years of age underwent isolated mitral valve replacement with a bioprosthesis. Thirty-nine of the 285 survivors experienced 48 pregnancies during the late follow-up period (group 1). Structural valve deterioration occurred in 25 (64.1%) of these patients and in 70 (28.4%) of the 246 patients (group 2) who did not become pregnant (p < 0.01). The mean time at which structural valve deterioration occurred was 7.01 ± 1.19 years postoperatively (range, 4.74 to 8.36 years) for group 1 patients and 6.76 ± 1.34 years (range, 2.33 to 10.17 years) for group 2 patients (p > 0.05). Freedom from structural valve deterioration at 10 years was 22.9% ± 8.11% for group 1 and 29.24% ± 6.09% for group 2 (p > 0.05). We concluded that pregnancy did not influence the long-term outcome after mitral valve replacement with a bioprosthesis.

scholarly journals Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic Review

2021 ◽  
Author(s):  
Sophia L. Alexis ◽  
Aaqib H. Malik ◽  
Ahmed El‐Eshmawi ◽  
Isaac George ◽  
Aditya Sengupta ◽  
...  
Keyword(s):  
High Risk ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Annular Calcification ◽  
High Risk Patients ◽  
Transcatheter Mitral Valve Replacement ◽  
Risk Patients ◽  
Annular Calcification

Abstract Mitral annular calcification with mitral valve disease is a challenging problem that could necessitate surgical mitral valve replacement (SMVR). Transcatheter mitral valve replacement (TMVR) is emerging as a feasible alternative in high‐risk patients with appropriate anatomy. PubMed, Embase, and Cochrane Central Register of Controlled Trials were searched from inception to December 25, 2019 for studies discussing SMVR or TMVR in patients with mitral annular calcification; 27 of 1539 articles were selected for final review. TMVR was used in 15 studies. Relevant data were available on 82 patients who underwent hybrid transatrial TMVR, and 354 patients who underwent transapical or transseptal TMVR. Outcomes on SMVR were generally reported as small case series (447 patients from 11 studies); however, 1 large study recently reported outcomes in 9551 patients. Patients who underwent TMVR had a shorter median follow‐up of 9 to 12 months (range, in‐hospital‒19 months) compared with patients with SMVR (54 months; range, in‐hospital‒120 months). Overall, those undergoing TMVR were older and had higher Society of Thoracic Surgeons risk scores. SMVR showed a wide range of early (0%–27%; median 6.3%) and long‐term mortality (0%–65%; median at 1 year, 15.8%; 5 years, 38.8%, 10 years, 62.4%). The median in‐hospital, 30‐day, and 1‐year mortality rates were 16.7%, 22.7%, and 43%, respectively, for transseptal/transapical TMVR, and 9.5%, 20.0%, and 40%, respectively, for transatrial TMVR. Mitral annular calcification is a complex disease and TMVR, with a versatile option of transatrial approach in patients with challenging anatomy, offers a promising alternative to SMVR in high‐risk patients. However, further studies are needed to improve technology, patient selection, operative expertise, and long‐term outcomes.

Ultrasonic Emulsification of Severe Mitral Annular Calcification During Mitral Valve Replacement

2022 ◽  
Author(s):  
Alexander A. Brescia ◽  
Liza M. Rosenbloom ◽  
Tessa M.F. Watt ◽  
Curtis S. Bergquist ◽  
Aaron M. Williams ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Annular Calcification ◽  
Ultrasonic Emulsification ◽  
Annular Calcification

The Art of SAPIEN 3 Transcatheter Mitral Valve Replacement in Valve-in-Ring and Valve-in-Mitral-Annular-Calcification Procedures

2021 ◽  
Vol 14 (20) ◽  
pp. 2195-2214
Author(s):  
Vasilis C. Babaliaros ◽  
Robert J. Lederman ◽  
Patrick T. Gleason ◽  
Jaffar M. Khan ◽  
Keshav Kohli ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Annular Calcification ◽  
Transcatheter Mitral Valve Replacement ◽  
Sapien 3 ◽  
Annular Calcification
Sign in / Sign up

Export Citation Format

Share Document